DEVELOP
Growth innovative SMBs action plan
GD¤co, ¤conomic Development Group
GD€co, the €conomic Development Group, aims to reflect on actions and tools that Lyonbiopole has to implement in order to support SMBs development. The GD€co also makes recommendations which will be implemented after approval by the Board of Directors.
There are 14 people “intuitu personae” involved in the support to company’s development and committed to Lyonbiopole: Agnès Savigner, Crealys - Cécile Réal, Ariana Pharma - Fabrice Plasson, Porteur de projet d’entreprise Amoéba - François Miceli, Sofimac Partners - François Valencony, Mérieux Développement - Gilles Alberici, Orega Biotech - Grégoire Franoux, Flamel Technologies - Karine Lignel, Vizille Capital Innovation - Laurent Buffat, Altrabio - Nicolas Pasqual, ImmunID - Sandra Dubos, Oseo - Stéphane Legastelois, Indicia Biotechnology - Thierry Abribat, Alizé Pharma - Tristan Rousselle, PX'Therapeutics
The GD€co meets every 3 to 4 months.
